HFA
TDOC icon

Hoover Financial Advisors’s Teladoc Health TDOC Stock Holding History

Hoover Financial Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-209
Closed -$40K – 437
2020
Q2 		$40K Buy
+209
New +$36.6K 0.02% 207

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DVF
Discovery Value Fund Singapore $34.7M AUM 58.56% 1-Year Est. Return

Hoover Financial Advisors's TDOC Position: Q3 2020 in Review

Hoover Financial Advisors sold out of Teladoc Health (TDOC) in Q3 2020, closing a stake of 209 shares — an estimated $40K sold.

Hoover Financial Advisors first reported a position in TDOC in Q2 2020 and held it in 1 quarter. The position peaked at $40K in Q2 2020. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

  • Hoover Financial Advisors reported no remaining Teladoc Health position as of Q3 2020 after selling out during the quarter.
  • Hoover Financial Advisors sold 209 Teladoc Health shares in Q3 2020, an estimated $40K.
  • Hoover Financial Advisors first reported a position in Teladoc Health in Q2 2020 and held it in 1 quarter.
  • Hoover Financial Advisors's Teladoc Health position peaked at $40K in Q2 2020.
  • 743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on Hoover Financial Advisors's 13F filing for Q3 2020, filed 21 Oct 2020.